Pathogenetic mechanisms and therapeutic aspects of OMEGA-3 polyunsaturated fatty acids in diabetes mellitus (literature review and own data)

Authors

  • V. Serhiyenko Lviv National Medical University named by Danylo Halitsky, Lviv, Ukraine
  • Azhmi S. Lviv National Medical University named by Danylo Halitsky, Lviv, Ukraine
  • Serhiyenko L. Lviv National Medical University named by Danylo Halitsky, Lviv, Ukraine
  • Serhiyenko A. Lviv National Medical University named by Danylo Halitsky, Lviv, Ukraine

DOI:

https://doi.org/10.21856/j-PEP.2018.4.06

Keywords:

omega-3 polyunsaturated fatty acids, mechanism of action, diabetes mellitus

Abstract

In the review the present day data and own results about mechanisms of omega-3 polyunsaturated fatty acids are presented. The peculiarities of influence on 1) glucose metabolism; 2) chronic inflammatory process; 3) platelet aggregation and hemostasis; 4) endothelial dysfunction; 5) blood pressure regulation; 6) parameters of the vascular wall rigidity; 7) heart rate variability; 8) development of arrhythmias are presented. Results of our study prove that its prescription is accompanied by hypolipidaemic effect. Numerous studies report salutary effects of omega-3 polyunsaturated fatty acids on cardiovascular diseases risk factors and justify the benefits of using this drug by diabetes mellitus.

References

American Diabetes Association. Diabetes Care 2016;39 (1): S1-2.

International Diabetes Federation. IDF Diabetes Atlas, 7 ed. 2015.

Marazzi G, Volterrani M, Rosano GM. Int J Cardiol 2008; 127 (1): 124-125. doi: http://doi.org/10.4239/wjd.v6.i2.245.

Rutter MK, Nesto RW. Eur Heart J 2011; 32 (18): 2247-2255. doi: http://doi.org/10.1093/eurheartj/ehr154.

Bonafini S, Antoniazzi F, Maffeis C, et al. Prostaglandins Other Lipid Mediat 2015; 120 (7): 72-79. doi: http://doi.org/10.1016/j.prostaglandins.2015.03.006.

Egan BT, Szeiffova BB, Viczenczova C, et al. Physiol Res 2016; 65 (1): 29-42.

Harris WS. Pharmacol Res 2007; 55 (3): 217-223.

Harris WS, von Schacky C. Prev Med 2004; 39 (1): 212-220.

von Schacky C. Curr Opin Clin Nutr Metab Care 2008;11 (2): 94-99.

Dhule SS, Gawali SR. Natl J Physiol Pharm Pharmacol 2014; 4 (2): 121-123.

Kandasamy N, Joseph F, Goenka N. Br J Diabet Vasc Dis 2008; 8 (3): 121-128.

Widmer RJ, Flammer AJ, Lilach O. et al. Am J Med 2015; 128 (3): 229-238. doi: http://doi.org/10.1016/j.amjmed. 2014.10.014.

de Roos B, Mavrommatis Y, Brouwer IA. Br. J. Pharmacol 2009;158(2): 413-428. doi: http://doi.org/10.1111/j.1476-5381.2009.00189.x.

Ebbesson SOE, Devereux RB, Cole S. et al. Am Heart J 2010; 159 (6): 1020-1025. doi: http://doi.org/10.1016/j.ahj.2010.03.001.

Bang HO, Dyerberg J. Dan Med Bull 1980; 27 (4): 202-205.

Ebbesson SOE, Tejero ME, Nobmann ED, et al. J Cardiometab Syndr 2007; 2 (4): 244-249.

ORIGIN Trial Investigators, Bosch J, Gerstein HC, et al. N Engl J Med 2012; 367 (4): 309-318. doi: http://doi.org/10.1056/NEJMoa1203859.

Lemaitre RN, King IB, Mozaffarian D, et al. Am J Clin Nutr 2003; 77 (2): 319-325.

Mozaffarian D, Lemaitre RN, Kuller LH, et al. Circulation 2003; 107 (10): 1372-1377.

Mozaffarian D, Geelen A, Brouwer IA, et al. Circulation 2005; 112 (13): 1945-1952.

Burr ML, Fehily AM, Gilbert JF, et al. Lancet 1989;2 (8666): 757-761.

Burr ML, Dunstan FD, George CH. J Membr Biol 2005;206 (2): 155-163.

Yokoyama M, Origasa H, Matsuzaki M, et al. Lancet 2007; 369 (9567): 1090-1098.

Geleijnse JM, Giltay EJ, Schouten EG, et al. Am Heart J 2010; 159 (4): 539-546. doi: http://doi.org/10.1016/j.ahj.2009.12.033.

Kromhout D, Giltay EJ, Geleijnse JM. N Engl J Med 2010;363 (21): 2015-2026. doi: http://doi.org/10.1056/NEJMoa1003603.

Rauch B, Schiele R, Schneider S, et al. Circulation 2010;122 (21): 2152-2159. doi: http://doi.org/10.1161/CIRCULATIONAHA.110.948562.

Carpentier YA., Portois L, Malaisse JW. Am J Clin Nutr 2006; 83: 1499-1504.

Chan DC, Watts GF, Barrett PH, et al. Diabetes 2002;51 (8): 2377-2386.

Davidson MH. Am J Cardiol 2006;98(4A): 27-33.

Jump DB. Curr Opin Lipidol 2008; 19 (3): 242-247.

Harris WS. Am J Clin Nutr 1997; 65 (5): 1645S-1654S.

Stalenhoef AF, de Graaf J, Wittekoek ME, et al. Atherosclerosis 2000; 153 (1): 129-138.

McKenney JM, Swearingen D, Di Spirito M, et al. J Clin Pharmacol 2006; 46 (7): 785-791.

Davidson MH, Stein EA, Bays HE, et al. Clin Ther 2007;29 (7): 1354-1367.

Bradberry JC, Daniel E, Hilleman DE. P T J 2013; 38 (11): 681-691.

Lovaza prescribing information. Research Triangle Park, North Carolina, 2014.

von Schacky C. Cell Mol Biol 2010; 56 (1): 90-98. doi: http://doi.org/10.3390/nu2030375.

Spallone V, Ziegler D, Freeman R, et al. Diabetes Metab Res Rev 2011; 27 (7): 639-653. doi: http://doi.org/10.1002/dmrr.1239.

Tesfaye S, Boulton AJ, Dyck PJ, et al. Diabetes Care 2010; 33 (12): 2285-2293. doi: http://doi.org/10.2337/dc10-1303.

Matthews DR, Hosker JP, Rudenski AS, et al. Diabetologia 1985; 28 (7): 412-419.

Lee TH, Hoover RL, Williams JD, et al. N Engl J Med 1985; 312 (19): 1217-1224.

Massaro M, Habib A, Lubrano L, et al. Proc Natl Acad Sci USA 2006; 103 (41): 15184-15189.

Serhan CN, Chiang N, Van Dyke TE. Nat Rev Immunol 2008; 8 (5): 349-361. doi: http://doi.org/10.1038/nri2294.

Trebble T, Arden NK, Stroud MA, et al. Br J Nutr 2003;90 (2): 405-412.

De Caterina R, Liao JK, Libby P. Am J Clin Nutr 2000;71 (1): S213-223.

Calder PC. Am J Clin Nutr 2006; 83 (6): 1505-1519. doi: http://doi.org/10.1093/ajcn/83.6.1505S.

Kristensen SD, Schmidt EB, Dyerberg J. J Intern Med 1989; 731: 141-150.

Kramer HJ, Stevens J, Grimminger F, et al. Biochem. Pharmacol 1996; 52 (8): 1211-1217.

Matesanz N, Park G, McAllister H, et al. Invest Ophthalmol Vis Sci 2010; 51 (12): 6815-6825. doi: http://doi.org/10.1167/iovs.10-5339

McDonald DM, O’Kane F, McConville M, et al. Diabetes Care 2013; 36 (4): 998-1005. doi: http://doi.org/10.2337/dc12-0304.

Dixon LJ, Morgan DR, Hughes SM, et al. Circulation 2003; 107 (13): 1725-1728. doi: http://doi.org/10.1016/j.amjcard.2008.12.028.

Block RC, Abdolani A, Smith B, et al. Prostaglandins Leukot Essent Fatty Acids 2013; 89 (1): 9-18.

Mori TA, Woodman RJ, Burke V, et al. Free Radic. Biol. Med 2003; 35 (7): 772-781.

Lee KW, Blann AD, Lip GY. Thromb. Res 2006; 118 (3): 305-312.

Tousoulis D, Kampoli A-M, Papageorgiou CTN, et al. Cur Vasc Pharmacol 2012; 10 (1): 4-18. doi: http://doi.org/10.2174/157016112798829760.

Zhang W, Fu F, Tie R, et al. Vasa 2013; 42 (6): 421-428. doi: http://doi.org/10.1024/0301-1526/a000311.

Colussi G, Catena C, Novello M, et al. available at: http://dx.doi.org/10.5772/63501.

Yeboah J, Folsom AR, Burke GL, et al. Circulation 2009; 120 (6): 502-509. doi: http://doi.org/10.1161/CIRCULATIONAHA. 109.864801.

Pase MP, Grima NA, Sarris J. Br J Nutr 2011; 106 (7): 974-980. doi: http://doi.org/10.1017/S0007114511002819.

Massin M, von Bernuth G. Pediatr Cardiol 1997; 18 (4): 297-302.

Maser RE, Lenhard MJ. J Clin Endocrinol Metab 2005; 90 (10): 5896-5903.

Reiffel JA, Mcdonald A. Am J Cardiol 2006; 98 (4A): 50-60.

Macchia A, Grancelli H, Varini S, et al. J Am Coll Cardiol 2013; 61 (4): 463-468. doi: http://doi.org/10.1016/j.jacc.2012.11.021.

Mozaffarian D, Wu JH. J Am Coll Cardiol 2011; 58 (20): 2047-2067. doi: http://doi.org/10.1016/j.jacc.2011.06.063.

Endo J, Arita M. J Cardiol 2016; 67 (1): 22-27. doi: http://doi.org/10.1016/j.jjcc.2015.08.002.

Downloads

Published

2021-08-17

How to Cite

Serhiyenko, V. ., Azhmi, S., Serhiyenko, L. ., & Serhiyenko, A. . (2021). Pathogenetic mechanisms and therapeutic aspects of OMEGA-3 polyunsaturated fatty acids in diabetes mellitus (literature review and own data). Problems of Endocrine Pathology, 66(4), 52-64. https://doi.org/10.21856/j-PEP.2018.4.06